A detailed history of Jump Financial, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 31,056 shares of AQST stock, worth $74,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,056
Previous 29,812 4.17%
Holding current value
$74,844
Previous $60,000 120.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.01 - $6.09 $2,500 - $7,575
1,244 Added 4.17%
31,056 $132,000
Q4 2023

Feb 07, 2024

BUY
$1.29 - $2.47 $38,457 - $73,635
29,812 New
29,812 $60,000
Q4 2021

Feb 10, 2022

SELL
$3.69 - $6.37 $183,393 - $316,589
-49,700 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$3.25 - $4.66 $61,977 - $88,866
19,070 Added 62.26%
49,700 $216,000
Q2 2021

Aug 13, 2021

BUY
$3.29 - $5.21 $100,772 - $159,582
30,630 New
30,630 $122,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $129M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.